Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.44
+1.85 (17.47%)
At close: Dec 8, 2025, 4:00 PM EST
12.59
+0.15 (1.21%)
After-hours: Dec 8, 2025, 7:43 PM EST
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $734.91 million as of December 8, 2025. Its market cap has decreased by -3.65% in one year.
Market Cap
734.91M
Enterprise Value
403.50M
1-Year Change
-3.65%
Ranking
Category
Stock Price
$12.44
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $734.91M, a decrease of -11.40%. That is a compound annual growth rate of -2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 625.62M | -11.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |